The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
J Crohns Colitis
; 8(2): 120-8, 2014 Feb.
Article
en En
| MEDLINE
| ID: mdl-23932783
Palabras clave
6-MMPR; 6-MP; 6-TGN; 6-TGTP; 6-methylmercaptopurine ribonucleotides; 6-thioguanine nucleotides; 6-thioguanine triphosphate; 95% CI; 95% confidence interval; AZA; Adalimumab; Azathioprine; C-reactive protein; CD; CDAI; CRP; Crohn's disease; Crohn's disease activity index; Drug interaction; HGPRT; HPLC; IBD; IMP; ITPase; MCV; Mercaptopurine; RBC; TDM; TPMT; Therapeutic drug monitoring; UC; azathioprine; high performance liquid chromatography; hypoxanthine-guanine phosphoribosyl transferase; inflammatory bowel disease; inosine monophosphate; inosine triphosphate pyrophosphatase; mean corpuscular volume; mercaptopurine; red blood cells; therapeutic drug monitoring; thiopurine S-methyltransferase; ulcerative colitis
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Azatioprina
/
Enfermedad de Crohn
/
Antiinflamatorios no Esteroideos
/
Anticuerpos Monoclonales Humanizados
/
Inmunosupresores
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Crohns Colitis
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Reino Unido